Javelin Biotech Aims to Develop Industry-Leading "Organ-on-a-Chip" Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc. Pharmaceutical Investing
FDA Accepts Supplemental New Drug Application for Pfizer's XALKORI® for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma Pharmaceutical Investing
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate Medical Device Investing
Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts Pharmaceutical Investing
Algernon Announces 50% Enrollment in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation Medical Device Investing
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel Biotech Investing
